MRK

HOLD

Merck & Company, Inc.

Healthcare · Rank #27 · Analyzed Jul 13, 2026

$123.54

Current Price

$185.94

Intrinsic Value

+50.5%

Upside/Downside

6.5/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus1/2 methods agree

Quality Score3.5/5.0

Framework RatingHOLD

Price vs Intrinsic ValueUndervalued by 50.5%

Fair Value Range

Low$92.83

Base (IV)$185.94

High$235.13

Entry Points

Conservative$64.98

Moderate$92.83

Aggressive$130.16

Quality & Moat Breakdown

Return on Equity18.9% → 1.0/1.0

Debt LevelD/E 107 → 0/1.0

Revenue QualityGrowth 7.8%, margin Δ-25.5% +recovery → 1.0/1.0

Moat Strength3.5/5 → 0.5/1.0

Profit Margins13.6% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.